Integrative Computational Analysis of Viral Glycoprotein Evolution and Antibody Escape Dynamics

Introduction

Viral glycoproteins are the primary determinants of host cell tropism and the principal targets of neutralizing antibody responses in infected or vaccinated hosts [1]. Their continuous evolution under selective pressure from host immunity drives antigenic drift, necessitating iterative updates to veterinary vaccines and diagnostic reagents [2, 3]. Integrative computational analysis now combines sequence surveillance, phylogenetic reconstruction, structural biology, and biophysical simulation to characterise glycoprotein evolution and predict antibody escape dynamics at molecular resolution [4, 5, 6]. This article reviews the key computational methodologies and their application to veterinary pathogens, with emphasis on cross-species transmission risk and vaccine design.

Sequence Surveillance and Phylogenetic Analysis

High-throughput sequencing of viral genomes from clinical and environmental samples provides the raw material for evolutionary analysis [7, 8]. For veterinary applications, global databases such as GISAID (for influenza A viruses) and community-curated repositories for coronaviruses and other pathogens enable real-time monitoring of amino acid substitutions in glycoprotein genes [2, 9]. Routine variant calling pipelines identify single nucleotide polymorphisms and insertion-deletion events that may alter receptor binding or antigenicity [8, 10].

Phylogenetic inference using maximum likelihood or Bayesian frameworks reconstructs the evolutionary history of glycoprotein lineages [11, 12]. For example, analysis of avian infectious bronchitis virus (IBV) spike protein sequences from broiler flocks in Uzbekistan revealed the co-circulation of GI-1, GI-13, and GI-23 genotypes, each exhibiting distinct patterns of amino acid variation in the hypervariable regions of the S1 subunit [11]. Similarly, whole-genome phylogenetics of chicken infectious anemia virus isolates from Egyptian poultry identified lineage-specific mutations in the VP1 capsid protein that correlate with altered pathogenicity [12].

Evolutionary rate estimation and selection pressure analyses (dN/dS ratios) pinpoint codons under positive selection, often corresponding to antibody epitopes or receptor-binding interfaces [8, 10]. Recurrent mutations at such sites are hallmarks of immune evasion [10]. Computational pipelines that integrate phylogenetics with structural mapping help prioritise mutations for functional characterisation [13, 14]. For a detailed discussion of mutation rate modeling, refer to the article on Evolutionary Dynamics and Computational Modeling of Viral Mutation Rates.

Structural Modeling and Molecular Dynamics

Three-dimensional structures of viral glycoproteins, obtained experimentally via cryo-electron microscopy or X-ray crystallography, or predicted computationally using tools such as AlphaFold2, serve as templates for mechanistic studies [15, 14, 16]. Homology modeling and ab initio methods extend structural coverage to less characterised veterinary viruses [4, 17].

Molecular dynamics (MD) simulations allow the exploration of glycoprotein conformational ensembles on microsecond to millisecond timescales [18, 19]. All-atom MD with explicit solvent reveals the dynamic behaviour of receptor-binding domains (RBDs), including loop motions, domain rotations, and exposure of cryptic epitopes [15, 20]. For the SARS-CoV-2 spike protein, MD simulations have elucidated how mutations such as N481K alter the conformational equilibrium of the RBD, affecting both ACE2 receptor affinity and antibody recognition [21]. Similarly, simulations of influenza hemagglutinin (HA) have mapped the pH-induced conformational changes required for membrane fusion [3].

Free energy perturbation and alchemical calculations provide quantitative estimates of mutation-induced changes in binding free energy between glycoproteins and host receptors or antibodies [5, 18]. The hierarchical mutational profiling approach described by Alshahrani et al. systematically evaluates the energetic impact of every possible amino acid substitution at an antibody-glycoprotein interface, identifying escape hotspots that confer resistance without compromising receptor binding [5, 6, 19, 20, 22]. These calculations often rely on the MM/GBSA or MM/PBSA methods applied to MD trajectories [23].

The integration of MD with metadynamics or replica exchange enhances sampling of rare events relevant to immune evasion, such as the opening of the receptor-binding site or the repositioning of glycans that shield epitopes [24]. Glycan shielding itself is a dynamic process; computational models that account for glycan flexibility are essential for predicting antibody accessibility [24]. For further details on simulation techniques, consult the article on Molecular Dynamics Simulations of Viral Spike Glycoproteins: Insights into Host Receptor Binding and Antibody Escape.

Predicting Antibody Escape Mutations

Epitope Mapping and Mutational Profiling

Deep mutational scanning (DMS) experimentally measures the fitness and antibody escape phenotype of thousands of single amino acid substitutions in a glycoprotein [25, 26]. Computational models trained on DMS data can generalise to predict escape mutations not yet observed in nature [25, 26]. Bayesian active learning, combined with biophysical features, has been used to prioritise high-fitness viral variants for experimental validation, accelerating the identification of emerging escape variants [25].

Structural analysis of antibody-glycoprotein complexes reveals the specific contacts that define neutralisation breadth [5, 6, 19]. Broadly neutralising antibodies (bnAbs) often target conserved, functionally constrained epitopes such as the receptor-binding site or the fusion peptide [5, 6, 27, 28]. Resistance to bnAbs can arise through direct epitope erosion (loss of contact residues) or through allosteric modulation of the epitope conformation [19, 16, 22]. The frustration landscape concept, which quantifies the energetic frustration of residue interactions in the antibody-antigen interface, has been applied to distinguish escape-prone from escape-proof epitopes [22].

Machine learning classifiers trained on structural and energetic features can predict whether a given mutation will reduce antibody binding [29, 26]. Features include changes in buried surface area, hydrogen bonding networks, van der Waals contacts, and local electrostatic potential [29]. For Omicron variants of SARS-CoV-2, such models correctly identified mutations that confer resistance to class I and class IV neutralizing antibodies [6, 20, 14]. The same framework is transferable to veterinary coronaviruses such as porcine epidemic diarrhea virus (PEDV) and feline infectious peritonitis virus (FIPV) by homology.

Role of Insertions and Deletions

Insertions and deletions (indels) in glycoprotein genes, particularly in hypervariable regions, are increasingly recognised as drivers of antigenic change [8]. In the SARS-CoV-2 spike protein, indels in the N-terminal domain and the RBD have been associated with altered glycan shield architecture and antibody evasion [8, 30]. Computational prediction of the structural impact of indels is more challenging than for point mutations but can be addressed through flexible loop modeling and MD refinement [13]. The functional relevance of such indels in animal coronaviruses (e.g., the S1/S2 cleavage site insertions in bat coronaviruses) underscores their importance in zoonotic potential [30].

For an expanded discussion of deep mutational scanning and machine learning in the context of antibody escape, see the article on Deep Mutational Scanning and Machine Learning for Predicting SARS-CoV-2 Spike Protein Evolution and Antibody Escape.

Zoonotic Spillover Risk and Vaccine Design

Computational analysis of glycoprotein evolution directly informs assessments of zoonotic spillover risk [3, 1]. Comparative structural modeling of ACE2 orthologues across mammalian species, combined with molecular docking, predicts which animal hosts are susceptible to a given coronavirus [1]. For example, the broad host range of SARS-CoV-2 was anticipated by sequence and structural comparisons of ACE2 from diverse vertebrates [1]. Similarly, analysis of HA receptor-binding specificity determines whether an avian influenza virus can bind human-type sialic acid receptors, a prerequisite for pandemic potential [3]. Methods for predicting receptor-binding dynamics across species are reviewed in the article on Computational Prediction of Viral Entry Dynamics: Spike Protein-Receptor Binding Affinity and Escape Mutations.

Vaccine design benefits from computational identification of epitopes that are both conserved across circulating strains and resistant to escape [5, 27, 31]. Immunoinformatic pipelines predict B-cell and T-cell epitopes from glycoprotein sequences and filter them for conservation, population coverage, and structural accessibility [31]. Structure-based design of immunogens that stabilise the prefusion conformation of fusion proteins (e.g., respiratory syncytial virus F protein, coronavirus spike) has been guided by MD simulations and free energy calculations [23, 16].

Nanobodies and other small binding proteins can be computationally optimised for broad neutralisation using Rosetta or deep learning approaches [23]. For instance, computational optimisation of a nanobody targeting the SARS-CoV-2 RBD improved binding affinity and breadth across variants while reducing the potential for escape [23]. Such strategies are directly applicable to veterinary pathogens for which monoclonal antibody therapeutics are being developed [28].

Table 1 summarises the key computational methods discussed and their primary applications in glycoprotein evolution and antibody escape prediction.

Table 1. Computational Methods for Viral Glycoprotein Analysis

Integrated Workflow

Figure 1 presents a Mermaid workflow that integrates the computational approaches described in this review, from sequence acquisition to actionable predictions for surveillance and vaccine design.

flowchart TD
    A[Viral Sequence Data], > B[Variant Calling & Quality Control]
    B, > C[Phylogenetic Reconstruction]
    C, > D[Selection Analysis dN/dS]
    D, > E[Identify Positively Selected Sites]
    E, > F[Map to 3D Glycoprotein Structure]
    F, > G[Molecular Dynamics Simulations]
    G, > H[Free Energy Calculations for Mutations]
    H, > I[Predict Antibody Escape Mutations]
    I, > J[Machine Learning Escape Classifier]
    J, > K[Validate with Deep Mutational Scanning]
    K, > L[Update Surveillance Targets]
    L, > M[Guide Vaccine Strain Selection]

The workflow begins with sequence data from field isolates or experimental passages [7, 2]. After variant calling [8], phylogenetic analysis identifies lineages and selection pressures [11, 12]. Positively selected sites are mapped to available structures [13, 14]. MD simulations and free energy calculations evaluate the functional impact of mutations [18, 6]. Machine learning classifiers integrate these data to predict escape [29, 26]. Predictions can be tested experimentally via DMS [25] and fed back into surveillance and vaccine design [31].

Integration with Structural Databases and Visualization

Interactive 3D visualisation tools, such as the 3D Protein Viewer integrated into this portal, allow readers to inspect glycoprotein structures and antibody complexes. Users can load coordinates of influenza HA, coronavirus spike, or other veterinary glycoproteins and highlight residues under positive selection or predicted as escape hotspots. For example, the RBD of the SARS-CoV-2 spike protein with the N481K mutation can be visualised to understand its impact on antibody binding [21]. Readers are encouraged to explore the article on Computational Prediction of Viral Glycoprotein Dynamics: From Sequence to 3D Structure and Immune Evasion for a tutorial on structural analysis.

Cross-referencing with databases such as GISAID for influenza and the ESC resource for SARS-CoV-2 immune escape variants [9] provides additional context for veterinary virologists monitoring emerging strains.

Conclusion

Integrative computational analysis of viral glycoprotein evolution and antibody escape dynamics is essential for understanding antigenic drift, predicting zoonotic spillover risk, and designing effective veterinary vaccines. Sequence surveillance and phylogenetics establish the evolutionary framework, while MD simulations and free energy calculations provide mechanistic insight into the molecular determinants of escape. Machine learning models trained on structural and energetic features generalise these insights to predict future escape mutations. The cross-species applicability of these methods, demonstrated for coronaviruses, influenza viruses, and other veterinary pathogens, underscores their utility in animal health. Continued development of integrated pipelines that combine simulation, machine learning, and experimental validation will accelerate the response to emerging viral threats in both veterinary and comparative medicine.

For further reading on related topics, see the articles on Computational Modeling of Viral Glycoprotein Evolution: Predicting Antigenic Drift Using Machine Learning and Structural and Evolutionary Dynamics of Zoonotic Viral Glycoproteins: Integrating Molecular Modeling, Sequence Surveillance, and Receptor Binding Prediction.

References

[1] Damas J, Hughes GM, Keough KC et al. Broad host range of SARS-CoV-2 predicted by comparative and structural analysis of ACE2 in vertebrates. Proc Natl Acad Sci U S A. 2020. URL: https://pubmed.ncbi.nlm.nih.gov/32826334/

[2] Telenti A, Hodcroft EB, Robertson DL. The Evolution and Biology of SARS-CoV-2 Variants. Cold Spring Harb Perspect Med. 2022. URL: https://pubmed.ncbi.nlm.nih.gov/35444005/

[3] King SB, Singh M. Comparative genomic analysis reveals varying levels of mammalian adaptation to coronavirus infections. PLoS Comput Biol. 2021. URL: https://pubmed.ncbi.nlm.nih.gov/34793437/

[4] Soares AP, Penteado AB, Teixeira JP et al. Integrative proteome-wide structural analysis and high-throughput docking identify broad-spectrum antiviral scaffolds against Zika, Yellow Fever, West Nile, Saint Louis encephalitis, and Usutu viruses. Front Cell Infect Microbiol. 2026. URL: https://pubmed.ncbi.nlm.nih.gov/42146096/

[5] Alshahrani M, Gatlin W, Ludwick M et al. Mechanisms of Binding and Immune Escape Resistance for Broadly Neutralizing Antibodies Targeting Distinct Conserved SARS-CoV-2 Spike Epitopes: A Hierarchical Approach Integrating Mutational Profiling and Energy Landscape Analysis. Int J Mol Sci. 2026. URL: https://pubmed.ncbi.nlm.nih.gov/42123600/

[6] Alshahrani M, Parikh V, Foley B et al. Dissecting binding and immune evasion mechanisms for ultrapotent Class I and Class 4/1 neutralizing antibodies of SARS-CoV-2 spike protein using a multi-pronged computational approach: neutral frustration architecture of binding interfaces and immune escape hotspots drives adaptive evolution. Phys Chem Chem Phys. 2026. URL: https://pubmed.ncbi.nlm.nih.gov/41623222/

[7] Chandy S, Kumar H, Pearl S et al. Whole genome analysis reveals unique traits of SARS-CoV-2 in pediatric patients. Gene. 2024. URL: https://pubmed.ncbi.nlm.nih.gov/38670399/

[8] Alisoltani A, Jaroszewski L, Iyer M et al. Increased Frequency of Indels in Hypervariable Regions of SARS-CoV-2 Proteins-A Possible Signature of Adaptive Selection. Front Genet. 2022. URL: https://pubmed.ncbi.nlm.nih.gov/35719386/

[9] Rophina M, Pandhare K, Shamnath A et al. ESC: a comprehensive resource for SARS-CoV-2 immune escape variants. Nucleic Acids Res. 2022. URL: https://pubmed.ncbi.nlm.nih.gov/34643704/

[10] Romero EV, Clyde AE, Giorgi EE et al. Recurrent mutations drive rapid HIV escape from two broadly neutralizing antibodies in vivo. Proc Natl Acad Sci U S A. 2026. URL: https://pubmed.ncbi.nlm.nih.gov/41980093/

[11] Ardicli O, Kanar TS, Ucar KB et al. First Molecular Characterization and Comprehensive Bioinformatic Analysis of Avian Infectious Bronchitis Virus from Uzbekistan Reveals GI-1, GI-13, and GI-23 Genotypes in Broilers. Viruses. 2026. URL: https://pubmed.ncbi.nlm.nih.gov/41902240/

[12] Soliman YA, Eman MSE, Maha ANG et al. Molecular characterization, evolutionary dynamics, and pathogenic assessment of chicken infectious anemia virus isolates circulating in Egyptian poultry. Poult Sci. 2026. URL: https://pubmed.ncbi.nlm.nih.gov/42061267/

[13] Feng Z, Huang J, Baboo S et al. Structural and functional insights into the evolution of SARS-CoV-2 KP.3.1.1 spike protein. Cell Rep. 2025. URL: https://pubmed.ncbi.nlm.nih.gov/40618371/

[14] Raisinghani N, Alshahrani M, Gupta G et al. AlphaFold2-Enabled Atomistic Modeling of Structure, Conformational Ensembles, and Binding Energetics of the SARS-CoV-2 Omicron BA.2.86 Spike Protein with ACE2 Host Receptor and Antibodies: Compensatory Functional Effects of Binding Hotspots in Modulating Mechanisms of Receptor Binding and Immune Escape. J Chem Inf Model. 2024. URL: https://pubmed.ncbi.nlm.nih.gov/38373700/

[15] Mancini T, Luchetti N, Macis S et al. Multimodal Structural Characterization of SARS-CoV-2 Spike Variants: Spectroscopic and Computational Insights. Int J Mol Sci. 2025. URL: https://pubmed.ncbi.nlm.nih.gov/41226381/

[16] Fagerlund R, Uğurlu H, Salminen P et al. Spike conformational tuning rather than epitope erosion drives SARS-CoV-2 resistance to broadly neutralizing antibodies. bioRxiv. 2026. URL: https://pubmed.ncbi.nlm.nih.gov/42079064/

[17] Davydenko VS, Shchemelev AN, Ostankova YV et al. Modeling Human Protein Physical Interactions Involved in HIV Attachment In Silico. Int J Mol Sci. 2025. URL: https://pubmed.ncbi.nlm.nih.gov/41303692/

[18] Truong Hoai L, Ilham B, Sompornpisut T et al. Mutation-driven adaptation of ACE2-RBD binding revealed by integrative molecular dynamics analysis. J Mol Graph Model. 2026. URL: https://pubmed.ncbi.nlm.nih.gov/41839468/

[19] Alshahrani M, Parikh V, Foley B et al. Dynamic mutational profiling of binding interactions and allosteric networks in conformational ensembles of the SARS-CoV-2 spike protein complexes with classes of antibodies targeting cryptic binding sites: confluence of binding and allostery determines molecular mechanisms and hotspots of immune escape. Phys Chem Chem Phys. 2025. URL: https://pubmed.ncbi.nlm.nih.gov/40842437/

[20] Alshahrani M, Parikh V, Foley B et al. Integrative Computational Modeling of Distinct Binding Mechanisms for Broadly Neutralizing Antibodies Targeting SARS-CoV-2 Spike Omicron Variants: Balance of Evolutionary and Dynamic Adaptability in Shaping Molecular Determinants of Immune Escape. Viruses. 2025. URL: https://pubmed.ncbi.nlm.nih.gov/40573332/

[21] Smatti MK, Al-Khatib H, Suleman M et al. Functional and structural characterization of the SARS-CoV-2 spike N481K mutation. Arch Virol. 2026. URL: https://pubmed.ncbi.nlm.nih.gov/42243594/

[22] Alshahrani M, Gatlin W, Ludwick M et al. Frustration Landscapes of Broadly Neutralizing SARS-CoV-2 Spike Antibodies Targeting Conserved Epitopes Reveal Energetic Logic of Escape-Proof and Escape-Prone Mechanisms. bioRxiv. 2026. URL: https://pubmed.ncbi.nlm.nih.gov/41959354/ *** Disclaimer: This article is for educational and informational purposes only. It is not intended to substitute for professional veterinary advice, diagnosis, treatment, or regulatory guidance. Always consult a licensed veterinarian or qualified specialist regarding animal health, disease diagnosis, and therapeutic decisions.

[23] Cao S, Sun B, Gao F. From immune evasion to broad in silico binding: computational optimization of SARS-CoV-2 RBD-targeting nanobody. Front Immunol. 2025. URL: https://pubmed.ncbi.nlm.nih.gov/40895570/

[24] Kumar A, Yadav AJ, Tripathi T et al. Glycan shielding and epitope reorganization drive sotrovimab resistance in SARS-CoV-2 Omicron variants. Arch Biochem Biophys. 2026. URL: https://pubmed.ncbi.nlm.nih.gov/42128042/

[25] Huot M, Wang D, Liu J et al. Predicting high-fitness viral protein variants with Bayesian active learning and biophysics. Proc Natl Acad Sci U S A. 2025. URL: https://pubmed.ncbi.nlm.nih.gov/40489612/

[26] Sheffield T, Bruneau RC, Won S et al. Combining machine learning and iterative experiments to keep pace with emerging viral variants of concern. PLoS Comput Biol. 2026. URL: https://pubmed.ncbi.nlm.nih.gov/42308256/

[27] Guerra D, Beaumont T, Radić L et al. Broad SARS-CoV-2 neutralization by monoclonal and bispecific antibodies derived from a Gamma-infected individual. iScience. 2023. URL: https://pubmed.ncbi.nlm.nih.gov/37841584/

[28] Ferrara F, De Berardinis F, Scognamiglio M et al. The Shifting Paradigm of Monoclonal Antibodies in COVID-19 Management: From Early Triumphs to Viral Resistance and Future Perspectives. Antibodies (Basel). 2026. URL: https://pubmed.ncbi.nlm.nih.gov/42345852/

[29] Chiu C, Jawaid MZ, Cox DL. Computational Study of Antibody Binding to SARS-CoV-2 Variants. Antibodies (Basel). 2026. URL: https://pubmed.ncbi.nlm.nih.gov/42345847/

[30] Zhou H, Chen X, Hu T et al. A Novel Bat Coronavirus Closely Related to SARS-CoV-2 Contains Natural Insertions at the S1/S2 Cleavage Site of the Spike Protein. Curr Biol. 2020. URL: https://pubmed.ncbi.nlm.nih.gov/32416074/

[31] Sarma VR, Olotu FA, Soliman MES. Integrative immunoinformatics paradigm for predicting potential B-cell and T-cell epitopes as viable candidates for subunit vaccine design against COVID-19 virulence. Biomed J. 2021. URL: https://pubmed.ncbi.nlm.nih.gov/34489196/

[32] Lahiri P, Das S, Thakur S et al. Fast Viral Diagnostics: FTIR-Based Identification, Strain-Typing, and Structural Characterization of SARS-CoV-2. Anal Chem. 2024. URL: https://pubmed.ncbi.nlm.nih.gov/39215696/

[33] Fendler A, Au L, Shepherd STC et al. Functional antibody and T cell immunity following SARS-CoV-2 infection, including by variants of concern, in patients with cancer: the CAPTURE study. Nat Cancer. 2021. URL: https://pubmed.ncbi.nlm.nih.gov/35121900/

[34] Maldonado LL, Bertelli AM, Kamenetzky L. Molecular features similarities between SARS-CoV-2, SARS, MERS and key human genes could favour the viral infections and trigger collateral effects. Sci Rep. 2021. URL: https://pubmed.ncbi.nlm.nih.gov/33602998/

[35] Fu JYL, Lim SK, Jalalonmuhali M et al. Immune Pressure From Plasma From Immunocompromised and Healthy Individuals Drives Differential SARS-CoV-2 Evolution and Escape Mutation Emergence. J Med Virol. 2026. URL: https://pubmed.ncbi.nlm.nih.gov/42272263/